Related Experiment Video
Updated: Jul 10, 2026
08:45
Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients
Published on: April 18, 2025
[Antihypertensive therapy according to the ESH/ESC guidelines]
Bernard Waeber1, François Feihl
1Division de physiopathologie clinique, CHUV, 1011 Lausanne. Bernard.Waeber@chuv.ch
Revue Medicale Suisse
|October 25, 2007
Summary
Updated European hypertension guidelines recommend diuretics, beta-blockers, calcium antagonists, ACE inhibitors, and ARBs as first-line treatments. Combination therapy is advised for severe hypertension or high cardiovascular risk.
Area of Science:
- Cardiology
- Hypertension Management
Context:
- Updated guidelines from the European Society of Hypertension and European Society of Cardiology.
- Focus on antihypertensive treatment strategies.
Purpose:
- To summarize the updated recommendations for first-line antihypertensive therapies.
- To highlight specific patient groups benefiting from combination therapy.
Summary:
- Diuretics, beta-blockers, calcium antagonists, angiotensin-converting enzyme inhibitors, and angiotensin II antagonists remain first-line options.
- Initiating treatment with a fixed-dose combination of two agents with different mechanisms is recommended.
- This approach is particularly indicated for patients with systolic blood pressure > 160 mmHg and/or diastolic blood pressure > 90 mmHg, and those at high cardiovascular risk.
Impact:
- Provides clinicians with current evidence-based recommendations for hypertension management.
- Facilitates optimized treatment strategies for patients with elevated blood pressure and cardiovascular risk.
- Aims to improve patient outcomes through effective blood pressure control.
Related Concept Videos
01:28Hypertension IV: Drug Therapy and Lifestyle Modifications
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
01:23Hypertension V: Nursing Management
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.